Insmed Historical Balance Sheet

INSM Stock  USD 74.09  0.94  1.29%   
Trend analysis of Insmed Inc balance sheet accounts such as Total Current Liabilities of 236.9 M or Property Plant And Equipment Net of 109.6 M provides information on Insmed's total assets, liabilities, and equity, which is the actual value of Insmed Inc to its prevalent stockholders. By breaking down trends over time using Insmed balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Insmed Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Insmed Inc is a good buy for the upcoming year.

Insmed Inventory

87.41 Million

  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

About Insmed Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Insmed Inc at a specified time, usually calculated after every quarter, six months, or one year. Insmed Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Insmed and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Insmed currently owns. An asset can also be divided into two categories, current and non-current.

Insmed Balance Sheet Chart

At this time, Insmed's Cash is very stable compared to the past year. As of the 26th of November 2024, Non Current Assets Total is likely to grow to about 420.8 M, though Retained Earnings are likely to grow to (3.3 B).

Total Assets

Total assets refers to the total amount of Insmed assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Insmed Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Insmed balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Insmed Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.
Most accounts from Insmed's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Insmed Inc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
At this time, Insmed's Cash is very stable compared to the past year. As of the 26th of November 2024, Non Current Assets Total is likely to grow to about 420.8 M, though Retained Earnings are likely to grow to (3.3 B).
 2021 2022 2023 2024 (projected)
Other Current Liabilities79.1M131.7M149.6M157.1M
Total Assets1.2B1.7B1.3B1.4B

Insmed balance sheet Correlations

0.910.96-0.340.890.59-0.960.920.910.960.920.990.890.950.610.740.970.950.90.990.90.890.870.880.940.54
0.910.96-0.610.730.78-0.940.960.710.90.950.880.760.890.810.560.910.970.810.890.770.850.880.910.960.44
0.960.96-0.550.880.77-0.990.980.770.950.970.920.840.960.780.670.970.980.940.940.840.860.930.890.980.44
-0.34-0.61-0.55-0.28-0.930.5-0.570.02-0.42-0.65-0.26-0.15-0.36-0.890.1-0.36-0.62-0.47-0.3-0.14-0.38-0.51-0.53-0.630.09
0.890.730.88-0.280.55-0.90.830.790.880.830.860.820.880.530.810.910.840.970.880.830.760.820.70.830.35
0.590.780.77-0.930.55-0.730.780.220.690.850.50.40.610.970.210.630.810.720.540.390.640.680.760.820.13
-0.96-0.94-0.990.5-0.9-0.73-0.97-0.78-0.95-0.96-0.92-0.88-0.98-0.75-0.7-0.99-0.97-0.95-0.94-0.88-0.86-0.93-0.9-0.96-0.49
0.920.960.98-0.570.830.78-0.970.710.910.960.870.80.930.790.680.950.960.910.90.810.820.90.880.950.41
0.910.710.770.020.790.22-0.780.710.780.680.950.860.820.240.730.840.750.710.940.880.70.740.660.740.53
0.960.90.95-0.420.880.69-0.950.910.780.950.90.820.920.690.740.950.940.910.930.830.960.820.940.940.55
0.920.950.97-0.650.830.85-0.960.960.680.950.860.750.890.850.590.920.990.910.890.760.890.860.930.990.4
0.990.880.92-0.260.860.5-0.920.870.950.90.860.890.930.530.70.940.910.841.00.90.810.870.820.910.53
0.890.760.84-0.150.820.4-0.880.80.860.820.750.890.90.440.730.90.790.80.891.00.730.810.730.780.6
0.950.890.96-0.360.880.61-0.980.930.820.920.890.930.90.660.730.990.910.910.940.910.810.920.860.90.58
0.610.810.78-0.890.530.97-0.750.790.240.690.850.530.440.660.190.660.810.70.570.430.630.710.780.810.22
0.740.560.670.10.810.21-0.70.680.730.740.590.70.730.730.190.770.580.730.720.750.730.550.550.560.38
0.970.910.97-0.360.910.63-0.990.950.840.950.920.940.90.990.660.770.930.940.960.910.860.920.880.920.54
0.950.970.98-0.620.840.81-0.970.960.750.940.990.910.790.910.810.580.930.910.930.790.870.90.921.00.42
0.90.810.94-0.470.970.72-0.950.910.710.910.910.840.80.910.70.730.940.910.870.80.790.880.790.90.34
0.990.890.94-0.30.880.54-0.940.90.940.930.891.00.890.940.570.720.960.930.870.910.840.880.840.930.52
0.90.770.84-0.140.830.39-0.880.810.880.830.760.91.00.910.430.750.910.790.80.910.730.820.740.780.6
0.890.850.86-0.380.760.64-0.860.820.70.960.890.810.730.810.630.730.860.870.790.840.730.690.930.860.5
0.870.880.93-0.510.820.68-0.930.90.740.820.860.870.810.920.710.550.920.90.880.880.820.690.760.890.37
0.880.910.89-0.530.70.76-0.90.880.660.940.930.820.730.860.780.550.880.920.790.840.740.930.760.920.65
0.940.960.98-0.630.830.82-0.960.950.740.940.990.910.780.90.810.560.921.00.90.930.780.860.890.920.41
0.540.440.440.090.350.13-0.490.410.530.550.40.530.60.580.220.380.540.420.340.520.60.50.370.650.41
Click cells to compare fundamentals

Insmed Account Relationship Matchups

Insmed balance sheet Accounts

201920202021202220232024 (projected)
Total Assets742.3M796.2M1.2B1.7B1.3B1.4B
Other Current Liab280K50.8M79.1M131.7M149.6M157.1M
Total Current Liabilities85.2M118.8M135.2M190.2M225.6M236.9M
Total Stockholder Equity261.7M275.9M410.5M88.0M(331.9M)(315.3M)
Property Plant And Equipment Net113.1M97.2M95.5M102.1M104.4M109.6M
Net Debt(90.4M)(127.9M)(104.5M)103.8M721.6M757.7M
Retained Earnings(1.5B)(1.8B)(2.3B)(2.7B)(3.4B)(3.3B)
Accounts Payable13.2M42.9M35.8M50.5M65.4M68.7M
Cash487.4M532.8M716.8M1.1B482.4M506.5M
Non Current Assets Total187.1M173.3M406.5M383.1M400.8M420.8M
Non Currrent Assets Other20.3M26.8M51.0M76.1M96.6M101.4M
Cash And Short Term Investments487.4M532.8M716.8M1.1B780.4M819.5M
Common Stock Total Equity897K1.0M1.2M1.4M1.6M804.3K
Common Stock Shares Outstanding84.6M97.6M112.1M123.0M140.4M147.5M
Liabilities And Stockholders Equity742.3M796.2M1.2B1.7B1.3B1.4B
Other Current Assets20.2M48.0M57.8M25.5M24.2M25.4M
Other Stockholder Equity1.8B2.1B2.7B2.8B3.1B3.3B
Total Liab480.6M520.3M833.0M1.6B1.7B1.7B
Property Plant And Equipment Gross113.1M97.2M95.5M102.1M149.0M156.5M
Total Current Assets555.2M622.9M837.0M1.3B929.1M975.5M
Accumulated Other Comprehensive Income(10K)193K968K756K(745K)(782.3K)
Common Stock897K1.0M1.2M1.4M1.5M837.2K
Other Assets72.5M70.0M51.0M113.7M130.7M137.3M
Good Will58.7M53.7M49.3M136.1M156.5M164.4M
Non Current Liabilities Total395.4M401.5M697.9M1.4B1.4B1.5B
Intangible Assets53.7M49.3M73.8M68.8M63.7M61.3M
Property Plant Equipment60.2M54.0M53.0M56.5M65.0M68.2M
Net Receivables19.2M16.6M24.4M29.7M41.2M43.2M
Short Long Term Debt Total397.0M404.8M612.3M1.2B1.2B1.3B
Long Term Debt335.9M356.3M566.6M1.1B1.2B1.2B
Inventory28.3M49.6M67.0M69.9M83.2M87.4M
Net Tangible Assets208.0M226.6M200.5M(116.9M)(134.5M)(127.7M)
Retained Earnings Total Equity(1.5B)(1.8B)(2.3B)(2.7B)(2.4B)(2.3B)
Capital Surpluse1.8B2.1B2.7B2.8B3.2B3.4B
Deferred Long Term Liab52.1M47.3M72.0M37.6M43.2M45.7M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.55)
Revenue Per Share
2.206
Quarterly Revenue Growth
0.182
Return On Assets
(0.26)
Return On Equity
(8.91)
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.